Do head and neck squamous cell carcinomas express EGFRvIII?
The EGFRvIII mutation is not present in HNSCC. Therefore, EGFRvIII does not influence treatment response in HNSCC and is not a usable clinical prognostic marker.
Volunteers recruited and supported by an intermediary organization can provide assistance to practices in implementing a preventive services office system.